Hormone replacement therapy, reproductive factors, and age-related macular degeneration: The salisbury eye evaluation project

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: To evaluate a potential relationship between hormone replacement therapy (HRT), reproductive factors and age-related macular degeneration (AMD). Methods: 1,458 female participants (age 65-84) from the Salisbury Eye Evaluation study were available for this cross-sectional analysis. AMD outcomes were identified by reading center assessment of fundus photographs. Results: Women who currently used HRT had a lower adjusted odds of large drusen (>125 μm) (OR = 0.5, 95% CI 0.2-1.0). Use of HRT was not statistically significantly associated with the prevalence of early AMD or advanced AMD, although the odds ratios were all much less than 1. Women who had had an increased number of births had a greater prevalence of large drusen (test of linear trend, p = 0.03). Conclusions: Current use of HRT was associated with a lower odds of large drusen, which may be predictive of advanced AMD. No statistically significant correlations were found between HRT or reproductive factors and early or advanced AMD.

Original languageEnglish (US)
Pages (from-to)37-45
Number of pages9
JournalOphthalmic Epidemiology
Volume12
Issue number1
DOIs
StatePublished - Feb 1 2005

Keywords

  • Age-related macular degeneration
  • Drusen
  • Estrogen
  • Hormone replacement therapy
  • Reproduction

ASJC Scopus subject areas

  • Epidemiology
  • Ophthalmology

Fingerprint Dive into the research topics of 'Hormone replacement therapy, reproductive factors, and age-related macular degeneration: The salisbury eye evaluation project'. Together they form a unique fingerprint.

Cite this